Skip links

GSS EU Science Funding Gateway

Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

HORIZON-MISS-2027-02-CANCER-05
Forthcoming
General information
ProgrammeHorizon Europe (HORIZON)
Programme divisionHorizon Europe Framework Programme (HORIZON); Global Challenges and European Industrial Competitiveness; Health
CallHORIZON-MISS-2027-02 (Supporting the implementation of the Cancer Mission)
Type of actionHORIZON-PCP HORIZON Pre-commercial Procurement
Type of MGAHORIZON Action Grant Budget-Based
Deadline modelsingle-stage
Planned opening date10 February 2027
Deadline date16 September 2027
StatusForthcoming
OECD fieldsClinical medicine, Health sciences
EC cross-cutting prioritiesDigital Agenda, Artificial Intelligence
Cluster or programme partEU Missions (HORIZON-MISS)
Thematic communities (as in the COST Action Graph)Cancer
Beneficiary categories (GSS model, in training)Researchers/Research Centers/Institutions
Topic description

Expected Outcome:

This action supports the follow-up to the July 2023 Communication on EU Missions assessment[1]. Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:

  • Public procurers, possibly in cooperation with private ones, in the area of cancer-centred healthcare stimulate the competitive development of market-ready, affordable, innovative solutions.
  • The chosen solutions take into consideration the needs of cancer patients living with and beyond cancer through research that supports end-user engagement using participative research models.
  • Procurers create opportunities for European health, technology and medical devices, industrial actors (including start-ups, spin-offs, spin-outs, scale-ups, SMEs) to bring to the market affordable innovations that are cost-efficient, safe and have demonstrated improved health outcomes for cancer patients living with and beyond cancer.
  • Procurers facilitate the commercialisation of innovative solutions for and with cancer patients by their successful suppliers through providing them with first customer references for the validation and first pilot deployment.
  • Policymakers, healthcare providers and professionals, cancer patients and their carers – each in their respective areas – exchange and adopt good practices and the best treatment, technology and medical device solutions that the market can deliver through participative research.

Scope:

Pre-commercial procurement (PCP) actions target consortia of procurers with similar needs that want to procure together the development of affordable, innovative solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines[2].

Proposals should address all of the following:

  • The focus should be on affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines that benefit cancer patients. Within this topic, it is possible to foresee the transfer and adaptation of solutions and/or interventions from other sectors to healthcare systems. It is open both to proposals requiring improvements based on one specific solution or technology, or medical device as well as to proposals requiring end-to-end solutions that need combinations of different types of innovation.
  • The requested innovative solutions for healthcare systems in the areas of affordable cancer technologies, cancer medical devices, or cancer medicines should be clinically validated, piloted or upscaled by the participating procurers in at least five different countries across the EU Member States and Associated Countries.
  • Continuous dialogue between the demand and supply side is required for the success of pre-commercial procurement. Therefore the effective involvement of end-users (e.g. academia, clinical teams, cancer patients and their caregivers/families, cancer patient representatives, local or regional medical services, hospitals, production facilities) must be considered in the proposal. To stimulate dialogue with the supply side, procurers are required to organise an open-market consultation before launching the procurement and to promote the call for tenders widely across Europe to potentially interested suppliers.
  • Procurers should declare in the proposal their interest to purchase at least one solution resulting from the PCP in case the PCP delivers successful solutions and indicate whether they will (1) procure the solution(s) as part of the PCP or (2) in a separate follow-up procurement after the PCP. In the first case, procurers can implement the project as a fast-track PCP (see general annex H) and foresee the budget to purchase at least one solution during the PCP. In the second case, the procurers must include in the proposal a deliverable that prepares the follow-up procurement to purchase successful solution(s) after the PCP.
  • Activities covered should support national healthcare systems and mobilise technical assistance and/or capacity building to other procurers beyond the project to mainstream PCP implementation and to remove obstacles for introducing the innovative solutions for the benefit of cancer patients to be procured into the market.

[1] EUR-Lex - 52023DC0457 - EN - EUR-Lex

[2] Pre-commercial procurement (PCP) actions target consortia of procurers with similar needs that want to procure together the development of affordable, innovative solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines. This topic does not provide direct funding to developers, industry or research organisations to perform R&D. They will be able to respond to the call for tenders launched by consortia of procurers funded under this call

Topic conditions and documents
">

General conditions

1. Admissibility conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligibility Conditions

The specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

The specific conditions are described in General Annex H.

PCP procurement costs are eligible.

The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the specific topic of the Work Programme

Budget overview
Topic and type of actionBudget 2027 (EUR)StagesOpening dateDeadlineContributions (EUR)Indicative number of grants
HORIZON-MISS-2027-02-CANCER-03 - HORIZON-RIA HORIZON Research and Innovation Actions24 000 000single-stage10 February 202716 September 20277 000 000 to 9 000 0003
HORIZON-MISS-2027-02-CANCER-02 - HORIZON-IA HORIZON Innovation Actions20 000 000single-stage10 February 202716 September 20277 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-06 - HORIZON-CSA HORIZON Coordination and Support Actions3 000 000single-stage10 February 202716 September 20273 000 0001
HORIZON-MISS-2027-02-CANCER-01 - HORIZON-RIA HORIZON Research and Innovation Actions32 323 812single-stage10 February 202716 September 20277 000 000 to 8 000 0004
HORIZON-MISS-2027-02-CANCER-05 - HORIZON-PCP HORIZON Pre-commercial Procurement26 000 000single-stage10 February 202716 September 20278 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-04 - HORIZON-RIA HORIZON Research and Innovation Actions10 000 000single-stage10 February 202716 September 20275 000 000 to 7 000 0003
Partner search
On the EU Funding & Tenders portal

The portal lists the partner search announcements published for this topic: open the topic on the portal and go to "Partner search announcements".

Through the GSS community

No requests yet for this call.

Post a partner request for this call

Topic Q&As

Questions and answers published by the EC for this topic are on the portal: open the topic on the portal and go to "Topic Q&As".

Get support

Online Manual is your guide on the procedures from proposal submission to managing your grant.

Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.

Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.

Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

National Contact Points (NCPs) – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).

Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk – contact the Funding & Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

European IPR Helpdesk assists you on intellectual property issues.

CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk – the European Standards Organisations advise you how to tackle standardisation in your project proposal.

The European Charter for Researchers and the Code of Conduct for their recruitment – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.

Partner Search help you find a partner organisation for your proposal.

Source

Content published by the European Commission on the EU Funding & Tenders portal, updated automatically.

This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag